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Case report
A 32-year-old man presented to the emergency depart-
ment complaining of  pleuritic chest pain, productive 
cough, shortness of  breath, and facial swelling. Contrast-
enhanced chest CT demonstrated a large anterior medias-
tinal mass and lymphadenopathy with resultant severe nar-
rowing of  the superior vena cava (Fig. 1). There was a geo-
graphic region of  poorly defined hypoattenuation involving 
segment IV of  the left lobe of  the liver, without evidence of 
architectural distortion or mass effect, on pulmonary arte-
rial phase postcontrast images (Fig. 2). The differential di-
agnosis for this lesion included focal fatty infiltration versus 
metastatic disease; however, malignancy was considered less 
likely given the shape, location, and lack of  mass effect re-
lated to the lesion. 
Open biopsy of  the mediastinal mass yielded a diagnosis 
of  large B-cell lymphoma. The patient underwent six cycles 
of  chemotherapy (CHOP, Rituxan). Followup chest CT 
performed during treatment three months later demon-
strated a slight reduction in the size of  the anterior medias-
tinal mass, with some improvement in the degree of  SVC 
compression. CT also demonstrated internal thoracic col-
laterals (Fig. 3) and paraumbilical veins in the region of  the 
falciform ligament (Figs. 4, 5). Note was also made of  a 
prominent azygos/hemiazygos system (Figs. 1, 3). There 
was abnormal parenchymal enhancement involving he-
patic segment IV in the region of  the falciform ligament 
(Figs. 4, 5), corresponding to the previously noted hypoat-
tenuating region on the first CT. This enhancement was 
thought to represent a pseudolesion related to collateral 
blood flow, given the evidence of  collateralization and 
nonmasslike appearance.  Two months later, the patient 
underwent evaluation with abdominal ultrasound, which 
demonstrated mildly increased echogenicity of  the liver 
diffusely without evidence of  focal mass to correlate with 
the findings on CT.
Fewer than three months after the followup CT, the pa-
tient underwent FDG-PET, which demonstrated intense 
FDG uptake in the anterior mediastinal mass, consistent 
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We present a case of  focal increased intrahepatic radiotracer activity on 18F-fluorodeoxyglucose positron 
emission tomography (FDG-PET) in a patient with lymphoma and superior vena cava (SVC) obstruc-
tion, a false positive for malignancy. Contrast-enhanced computed tomography (CT) demonstrated an 
enhancing region of  geographic focal hypoattenuation in the liver along the falciform, corresponding to 
the region of  increased radiotracer activity on FDG-PET, with marked narrowing of  the superior vena 
cava and resultant collateral venous pathways to the portal vein via paraumbilical veins. CT followup 
demonstrated stability of  the hepatic abnormality, and no lesion was evident on ultrasound, suggesting 
that the finding on PET-CT represented a false positive for malignancy in this patient with known SVC 
obstruction. In patients with SVC obstruction, radiologists should consider this phenomenon of  anoma-
lous hepatic uptake along the falciform as a source of  possible false positives for malignancy on PET.
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Figure 1. Initial thoracic CT of a 32-year-old man with SVC obstruction secon-
dary to biopsy-proven large B-cell lymphoma. Images were obtained in arterial 
contrast phase following intravenous administration of 80 mL Omnipaque 350 
via the right upper extremity. Figs 1A-C were obtained in the axial plane, and D 
is a coronal reconstruction. The images reveal a large anterior mediastinal mass 
(black star, A-D) narrowing of the SVC (thick white arrows, A, C, D), a prominent 
azygos vein (thin white arrows, B, C) and mild prominence of the internal tho-
racic veins (black arrows, B, C).
Figure 2. Axial images are from the same study as Fig. 1, also in early phase of 
contrast enhancement, windowed for improved definition of the hepatic paren-
chyma. There is a geographic area of low attenuation involving segment IV of 
the left lobe of the liver (thick white arrows, A-D). Incidental note is made of a 
pericardial effusion (thin white arrow, A).
Figure 3. Fol-
lowup contrast-
enhanced CT 
evaluation per-
formed three 
months after the 
initial CT, follow-
ing 6 cycles of 
chemotherapy. 
Axial, contrast-
enhanced CT 
was obtained in 
portal venous 
phase following 
intravenous in-
jection of 80 mL 
Omnipaque 350 
via the left upper 
extremity with 
coronal recon-
struction (E). 
There are multi-
ple prominent 
collateral veins 
including: chest 
wall (blue ar-
rows, A, B, E), 
paravertebral 
(small black 
arrows, A, C), 
prominent azy-
gos (thick white 
arrows, C, D), 
hemiazygos 
(thin white ar-
rows, B), and 
internal thoracic 
collaterals (thick 
black arrows, 
C-E).
with the patient’s known lymphoma (maximum standard-
ized uptake value, SUVmax, 9.4) (Fig. 6b).  Besides the 
known mediastinal lymphoma, the only other concerning 
PET finding was focally increased FDG accumulation of  
moderate intensity corresponding to a poorly defined 
2.5-x-3.0cm hypoattenuating region toward the inferior 
aspect of  segment IV of  the left lobe of  the liver adjacent 
to the falciform ligament, with SUVmax of  5.0 (Fig. 6). 
The differential for focally increased hepatic activity gener-
ally includes misregistration artifact from diaphragmatic 
motion and metabolic activity within the adjacent bowel 
(which had been confidently excluded in this case, 
as there was no evidence of  misregistration, no 
nearby bowel activity of  sufficient intensity to ac-
count for the hepatic finding, and the focal in-
creased hepatic activity conformed to the shape of 
the liver in three planes and on the MIP, corre-
sponding to the finding on CT) versus primary or 
secondary hepatic neoplasm, most likely meta-
static lymphoma in this case. When interventional 
radiology (IR) was consulted for liver biopsy and 
reviewed the CT findings, IR strongly concurred 
with the CT interpretation favoring a benign eti-
ology for the CT finding, which had been stable in 
size for three months, likely related to collateral 
blood flow, prompting the question, “Could the 
focal abnormal increased FDG uptake on PET 
also be due to collateral blood flow, rather than a 
hypermetabolic mass?” A literature search identi-
fied one published report in the thoracic imaging 
literature of  focal liver uptake in this same region 
on FDG-PET in two lung cancer patients with 
SVC obstruction (1). Given the previously re-
ported PET finding and the CT features favoring 
benignity of  the lesion, liver biopsy was deferred in 
favor of  CT followup, which thereafter docu-
mented stability of  the hepatic finding for 14 
months (Fig. 7) and favored a nonmalignant 
etiology.
Discussion
In patients with SVC obstruction, areas of  focal 
increased hepatic blood flow secondary to collat-
eralization and systemic-portal venous shunting 
have been well documented. The result of  this 
shunting has previously been demonstrated as 
abnormal enhancement on contrast-enhanced CT 
and as focal increased radiotracer uptake on nu-
clear medicine Tc-99m sulfur colloid scan, some-
times referred to as the “focal hepatic hot spot” 
sign (2, 3, 4-6).  This finding of  focal hepatic en-
hancement or focal increased radiotracer activity 
is thought to be due to high concentrations of  in-
jected contrast or radiopharmaceuticals delivered 
to the left portal or subcapsular liver veins via col-
lateral flow. There are several potential collateral 
pathways in SVC obstruction. These include the 
internal thoracic vein to the portal vein via the 
umbilical or paraumbilical veins, leading to focal flow to 
the liver in the region of  the falciform ligament (7). There 
are also the lateral thoracic veins, superficial veins, azygos-
hemiazygos, and paravertebral collateral systems (6-8). 
In this patient with lymphoma, contrast-enhanced CT 
demonstrated obstruction of  the SVC with internal tho-
racic collaterals to the anterior paraumbilical vessels as well 
as azygos/hemiazygos and paravertebral collateralization. 
On early pulmonary arterial-phase CT, a focal nonmass-
like area of  hypoattenuation was noted adjacent to the fal-
ciform ligament, which demonstrated avid enhancement 
Focal hepatic uptake along the falciform: False positive for malignancy on 18F-FDG-PET
RCR Radiology Case Reports | radiology.casereports.net! 3! 2014 | Volume 9 | Issue 1
Figure 5. Coronal reconstructions of the contrast-enhanced portal venous phase 
CT images in Figs. 3 and 4, using 80mL Omnipaque 350 i.v. via the left upper 
extremity. The thin white arrows indicate the recanalized paraumbilical vein (A, 
B). There is hyperenhancement along the falciform ligament (thin black arrows, 
B, C). The thick black arrows indicate chest wall collaterals (B, C) and the thick 
white arrow indicates the internal thoracic vein (C).
Figure 4. Axial, contrast-enhanced portal venous phase CT images from the 
same study as Fig 3, obtained more inferiorly. There is recanalization of the 
paraumbilical vein (white arrows, A, B), draining to the anterior liver, resulting in 
hyperenhancement of segment IV of the left lobe of the liver, correlating with the 
region of hypoattenuation seen on the prior CT (black arrows, C, D). 
during the portal venous phase. Subsequent 
PET then demonstrated focal increased FDG 
uptake in this same region. It is important to 
remember that the liver has been reported to 
be frequently involved in patients with non-
Hodgkin’s lymphoma (9). Indeed, in a patient 
being staged for known malignancy without 
SVC obstruction, focally increased FDG accu-
mulation at a site of  abnormal attenuation/
enhancement on CT would have high specific-
ity for malignancy. FDG-PET has a reported 
specificity of  between 90% and 96% for liver 
metastases from gastrointestinal primaries 
(10-12). Hence, it is important for interpreters 
of  PET to be aware of  this phenomenon in 
patients with SVC obstruction as a potential 
false positive mimicking hepatic malignancy. 
    If  further imaging evaluation to confirm 
false positive due to SVC obstruction is desired, 
the PET study could be repeated using an in-
travenous injection site on the lower extremity 
(for example, in a foot vein). The initial passage 
of  concentrated radiotracer from the lower 
extremity via the nonobstructed inferior vena 
cava (rather than from upper extremity via 
collaterals bypassing the obstructed superior 
vena cava) would not be expected to reproduce 
a false positive hepatic finding due to SVC ob-
struction. This result has been confirmed using 
Tc-99m sulfur colloid in a patient with medias-
tinal mass due to metastatic breast cancer.  In-
jection via the right antecubital fossa revealed a 
warm spot within the anterior liver, but no focal 
hepatic uptake with injection of  the dorsum of  
the right foot (5).  
    In the case of  our patient, IR did not feel 
that a repeated PET/CT was needed for pa-
tient management and therefore opted to spare 
him the additional cost and radiation. After 
documented continued stability of  the hepatic 
finding on CT for a total of  14 months, the 
patient was lost to followup. Considering the 
stability and the other features in this patient, it 
is thought very likely that the hepatic PET find-
ing was also benign, related to the collateral 
blood flow of  SVC obstruction. In a patient 
with SVC obstruction and isolated focal hepatic 
activity on FDG-PET along the falciform, in-
terpreters of  PET should consider this artifact 
in the differential. 
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